BRIEF — GenFleet Therapeutics (Shanghai) Says GFH375 Combined With Cetuximab Placed On Proposed BTD List

Sept 22 (Reuters) — GenFleet Therapeutics (Shanghai) Inc: Gfh375 Combined With Cetuximab Placed On Proposed Breakthrough Therapy Designation List By Nmpa On Sep 18 Further company coverage: 2595.HK (Reuters.Briefs@thomsonreuters.com;)